In addition, miR-29c-3p inhibits the expression of DNMT3B and promotes LATS1 demethylation, which restores its expression and subsequently activates the Hippo signaling pathway to inhibit the malignant development of HCC. This evidence concerns the gene DNMT3B and hepatocellular carcinoma.